Australia Medication Assisted Therapy (MAT) Market to 2032
Overview
The Australia Medication Assisted Therapy (MAT) Market is expected to reach a 480.33 by 2032 and is projected to grow at a CAGR of 15.62% from 2025 to 2032.
Revenue, 2024 ()
225.70
Forecast, 2032 ()
480.33
CAGR, 2024 - 2032
15.62%
Report Coverage
Australia
Australia Medication Assisted Therapy (MAT) Market 2018-2032
Australia Medication Assisted Therapy (MAT) Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 225.70
- Projected Market Size (2032): 480.33
- CAGR (2025-2032): 15.62%
Key Findings of Australia Medication Assisted Therapy (MAT) Market
- The Australia Medication Assisted Therapy (MAT) Market was valued at 225.70 in 2024.
- The Australia Medication Assisted Therapy (MAT) Market is likely to grow at a CAGR of 15.62% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Adults in Population Type Segment accounted for the largest share of the market with a revenue of 212.12
- The fastest growing segment Buprenorphine and Naloxone in Products Segment grew Fastest with a CAGR of 18.35% during the forecast period from 2024 to 2032.
Australia Medication Assisted Therapy (MAT) Market Scope
Australia Medication Assisted Therapy (MAT) Market Segmentation & Scope
Type
- Therapy
- Medication
Products
- Acamprosate
- Disulfarm
- Naloxone
- Metadone
- Buprenorphine
- Naltrexone
- Buprenorphine and Naloxone
Drug Type
- Branded
- Generics
Dosage Form
- Extented Release
- Immediate Release
Distribution Channel
- Others
- Online Pharmacy
- Retail Pharmacy
- Direct Tender
- Hospital Pharmacy
Route of Administration
- Others
- Parenteral
- Oral
Population Type
- Teenage
- Adults
End User
- Others
- Homecare
- Speciality Centers
- Hospitals
- Rehabilitation Clinics
Australia Medication Assisted Therapy (MAT) Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2020 |
| Unit | Revenue in |
| Market Value in 2024 | 225.70 |
| Market Value in 2032 | 480.33 |
| CAGR (2025-2032) | 15.62% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Type,Products,Drug Type,Dosage Form,Distribution Channel,Route of Administration,Population Type,End User |
Regional Insights:
-
Leading Market (2024-2032): Australia, leading in terms of revenue 225.70 in 2024
- Key Country: Australia, leading in terms of revenue with value of 225.70 in 2024.
Segments and Scope
-
Australia Medication Assisted Therapy (MAT) Market to 2032, By Type
- Medication is the largest segment in Australia Medication Assisted Therapy (MAT) Market to 2032 with a revenue of 124.87 in the year 2024.
- Medication is the Fastest growing segment in Australia Medication Assisted Therapy (MAT) Market to 2032 with a Growth rate of 16.36 % in forecast period 2025-2032.
-
Australia Medication Assisted Therapy (MAT) Market to 2032, By Products
- Buprenorphine and Naloxone is the largest segment in Australia Medication Assisted Therapy (MAT) Market to 2032 with a revenue of 30.75 in the year 2024.
- Buprenorphine and Naloxone is the Fastest growing segment in Australia Medication Assisted Therapy (MAT) Market to 2032 with a Growth rate of 18.35 % in forecast period 2025-2032.
-
Australia Medication Assisted Therapy (MAT) Market to 2032, By Drug Type
- Generics is the largest segment in Australia Medication Assisted Therapy (MAT) Market to 2032 with a revenue of 115.73 in the year 2024.
- Generics is the Fastest growing segment in Australia Medication Assisted Therapy (MAT) Market to 2032 with a Growth rate of 16.50 % in forecast period 2025-2032.
-
Australia Medication Assisted Therapy (MAT) Market to 2032, By Dosage Form
- Immediate Release is the largest segment in Australia Medication Assisted Therapy (MAT) Market to 2032 with a revenue of 76.11 in the year 2024.
- Immediate Release is the Fastest growing segment in Australia Medication Assisted Therapy (MAT) Market to 2032 with a Growth rate of 16.95 % in forecast period 2025-2032.
-
Australia Medication Assisted Therapy (MAT) Market to 2032, By Distribution Channel
- Hospital Pharmacy is the largest segment in Australia Medication Assisted Therapy (MAT) Market to 2032 with a revenue of 68.48 in the year 2024.
- Hospital Pharmacy is the Fastest growing segment in Australia Medication Assisted Therapy (MAT) Market to 2032 with a Growth rate of 17.21 % in forecast period 2025-2032.
-
Australia Medication Assisted Therapy (MAT) Market to 2032, By Route of Administration
- Oral is the largest segment in Australia Medication Assisted Therapy (MAT) Market to 2032 with a revenue of 68.04 in the year 2024.
- Oral is the Fastest growing segment in Australia Medication Assisted Therapy (MAT) Market to 2032 with a Growth rate of 17.20 % in forecast period 2025-2032.
-
Australia Medication Assisted Therapy (MAT) Market to 2032, By Population Type
- Adults is the largest segment in Australia Medication Assisted Therapy (MAT) Market to 2032 with a revenue of 212.12 in the year 2024.
- Adults is the Fastest growing segment in Australia Medication Assisted Therapy (MAT) Market to 2032 with a Growth rate of 15.74 % in forecast period 2025-2032.
-
Australia Medication Assisted Therapy (MAT) Market to 2032, By End User
- Rehabilitation Clinics is the largest segment in Australia Medication Assisted Therapy (MAT) Market to 2032 with a revenue of 99.92 in the year 2024.
- Rehabilitation Clinics is the Fastest growing segment in Australia Medication Assisted Therapy (MAT) Market to 2032 with a Growth rate of 16.81 % in forecast period 2025-2032.
Australia Medication Assisted Therapy (MAT) Market Company Share Analysis
| Company Name |
|
||
| Viatris Inc. | |||
| Indivior PLC | |||
| Mallinckrodt | |||
| Sun Pharmaceutical Industries Ltd. | |||
| Teva Pharmaceutical Industries Ltd. | |||
Australia Medication Assisted Therapy (MAT) Market Geographical Sales Distribution, 2018-2032
Australia Medication Assisted Therapy (MAT) Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Australia Medication Assisted Therapy (MAT) Market is segmented based on Segmentation Type,Products,Drug Type,Dosage Form,Distribution Channel,Route of Administration,Population Type,End User.
Australia Medication Assisted Therapy (MAT) Market was valued at USD 225.70(Revenue in ) in 2020.
Australia Medication Assisted Therapy (MAT) Market is projected to grow at a CAGR of 15.62% during the forecast period of 2024 to 2032.
The Adults segment is expected to dominate the Australia Medication Assisted Therapy (MAT) Market, holding a largest market share of 212.12 in 2024
Coming Soon....
Australia Medication Assisted Therapy (MAT) Market Scope
Australia Medication Assisted Therapy (MAT) Market Segmentation & Scope
Type
- Therapy
- Medication
Products
- Acamprosate
- Disulfarm
- Naloxone
- Metadone
- Buprenorphine
- Naltrexone
- Buprenorphine and Naloxone
Drug Type
- Branded
- Generics
Dosage Form
- Extented Release
- Immediate Release
Distribution Channel
- Others
- Online Pharmacy
- Retail Pharmacy
- Direct Tender
- Hospital Pharmacy
Route of Administration
- Others
- Parenteral
- Oral
Population Type
- Teenage
- Adults
End User
- Others
- Homecare
- Speciality Centers
- Hospitals
- Rehabilitation Clinics
Frequently Asked Questions
The Australia Medication Assisted Therapy (MAT) Market is segmented based on Segmentation Type,Products,Drug Type,Dosage Form,Distribution Channel,Route of Administration,Population Type,End User.
Australia Medication Assisted Therapy (MAT) Market was valued at USD 225.70(Revenue in ) in 2020.
Australia Medication Assisted Therapy (MAT) Market is projected to grow at a CAGR of 15.62% during the forecast period of 2024 to 2032.
The estimated market value of the Australia Medication Assisted Therapy (MAT) Market for final year is USD 480.33 ().
Australia Medication Assisted Therapy (MAT) Market Company Profiling
Frequently Asked Questions
The Australia Medication Assisted Therapy (MAT) Market is segmented based on Segmentation Type,Products,Drug Type,Dosage Form,Distribution Channel,Route of Administration,Population Type,End User.
Australia Medication Assisted Therapy (MAT) Market was valued at USD 225.70(Revenue in ) in 2020.
Australia Medication Assisted Therapy (MAT) Market is projected to grow at a CAGR of 15.62% during the forecast period of 2024 to 2032.
The estimated market value of the Australia Medication Assisted Therapy (MAT) Market for final year is USD 480.33 ().
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.